in

GSK selling $3.45 bln stake in Hindustan Unilever

1588794884_photo.jpg



GlaxoSmithKline is selling $3.45 billion worth of shares in Unilever’s Indian business on the open market, one of the bookrunners organising the transaction told Reuters.The 5.7% stake in Hindustan Unilever, now put on the market, was accepted by GSK as payment for the sale of malted drink brand Horlicks and other nutrition brands to Unilever, agreed in late 2018.GSK declined to comment.IFR earlier reported the transaction.



Source link

Written by sortiwa

Bat-virus adaptation may explain species spillover, researchers say — ScienceDaily

Cholesterol lowering drugs linked to improved gut bacteria composition in obese people — ScienceDaily